Codex DNA to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
November 02, 2021 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its third quarter 2021...
Codex DNA Reports Second Quarter 2021 Financial Results
August 10, 2021 16:15 ET
|
Codex DNA, Inc.
SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the second quarter ended...
Codex DNA Announces Synthetic Biology Collaboration with U.S. Department of Agriculture to Combat Citrus Greening Disease
August 05, 2021 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a collaboration with researchers from the U.S....
Codex DNA to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
August 03, 2021 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), the pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2021...
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology
July 21, 2021 07:07 ET
|
Codex DNA, Inc.
SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink...
Codex DNA Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
June 22, 2021 16:10 ET
|
Codex DNA, Inc.
SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full...
Codex DNA Announces Pricing of Initial Public Offering
June 17, 2021 22:16 ET
|
Codex DNA, Inc.
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows,...
Codex DNA Announces Launch of Initial Public Offering
June 14, 2021 09:15 ET
|
Codex DNA, Inc.
SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows,...